Guselkumab (Tremfya)

guselkumab · Janssen Biotech, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Guselkumab (Tremfya), covering 2026-03-02 to 2026-03-02. Get the full timeline:

Most recent: Clinical Trial Update: Guselkumab Vs Ustekinumab in Stricturing Crohn's Disease